---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-24-006319"
form_type: "8-K"
ticker: "TECH"
cik: "0000842023"
company_name: "BIO-TECHNE Corp"
filed_at: "2024-05-01T23:59:59+00:00"
generated_at: "2026-06-03T03:38:40.108826+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Bio-Techne Q3 FY2024: Revenue $303.4M (+2% organic); GAAP EPS $0.31 vs $0.43; declares $0.08 dividend

## Summary
- Q3 revenue $303.4M (organic +2%, reported +3%); GAAP EPS $0.31 vs $0.43; adjusted EPS $0.48 vs $0.53.
- Diagnostics & Genomics segment organic growth 10% (reported 16%); record GMP reagent sales in cell/gene therapy.
- Cash from operations $223.5M, up 31% YoY.
- Quarterly dividend of $0.08 per share, payable May 24, 2024; record date May 13, 2024.

## SEC filing metadata
- accession: 0001558370-24-006319
- form_type: 8-K
- ticker: TECH
- cik: 0000842023
- company_name: BIO-TECHNE Corp
- filed_at: 2024-05-01T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/842023/000155837024006319/0001558370-24-006319-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/842023/000155837024006319/tmb-20240501x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-24-006319
- JSON: https://secwatch.observer/filing/0001558370-24-006319.json
- Plain text: https://secwatch.observer/filing/0001558370-24-006319.txt

## Key facts
- Earnings Releases
  BIO-TECHNE Corp reported the third quarter ending March 31, 2024 results: revenue $303.4 million, EPS $0.31.
  - Period: the third quarter ending March 31, 2024
  - Revenue: $303.4 million
  - EPS: $0.31
  - Result: reported results
  source text: reported its financial results for the third quarter ending March 31, 2024. ​ Third Quarter FY2024 Highlights ​ ● Third quarter organic revenue increased by 2% (3% reported) to $303.4 million. ​ ● GAAP earnings per share (EPS) was $0.31 versus $0.43 one year ago. Delivered adjusted EPS of $0.48 compared to $0.53 one year ago. ​ ● Strong commercial execution in
  evidence_url: https://www.sec.gov/Archives/edgar/data/842023/000155837024006319/0001558370-24-006319-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.